| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT01261702 Details | 2013-02-18 Interventional | 4 | 32 | Magnesium Sulfa… Magnesium Sulph… Pain Post Pulmonary … | not include patient anymore - | |||
| NCT01463215 Details | 2013-02-15 Interventional | 1/2 | - | Ambroxol Gaucher Disease Type I Gaucher … | - - | |||
| NCT01510977 Details | 2013-02-13 Interventional | 4 | 150 | Bisacodyl Colonoscopy Fai… Poor Bowel Prep… | - - | |||
| NCT01481610 Details | 2013-02-13 Interventional | 2 | 28 | Diclofenac Lumiracoxib Arthralgia Kidney Failure,… Renal Insuffici… | Interim analysis shows harma to one of the study arms. - | |||
| NCT01067326 Details | 2013-02-13 Interventional | 3 | 22 | Aliskiren Atherosclerosis Endothelial Dys… | Novartis ended all studies regarding Aliskiren. The study was terminated early due to safety concerns from the ALTITUDE trial; there was an unexpected increase in adverse events (non-fatal stroke, renal complications, hyperkalemia and hypotension). Novartis ended all studies regarding Aliskiren. | |||
| NCT01198873 Details | 2013-02-12 Interventional | 4 | 76 | Dronedarone Atrial Fibrilla… | - Due to the early termination of the study, results should be cautiously interpreted. Indeed the number of participants was lower than planned (76 instead of 334) and the treatment period was shorter than planned (6 months instead of 12 months). | |||
| NCT00447265 Details | 2013-02-12 Interventional | 2 | 1 | Etanercept Lupus Nephritis Nephritis | The perceived risk-benefit ratio for individuals with early active RA The study terminated early with 1 subject enrolled. Based on safety info from other trials, the protocol chairs decided possible risks to patients outweighed the potential benefits. Analysis of groups is not possible. Study objectives cannot be met. | |||
| NCT00396812 Details | 2013-02-12 Interventional | 1/2 | 4 | Rituximab Arthritis Arthritis, Rheu… Rheumatoid Arth… | The perceived risk-benefit ratio for individuals with early active RA The trial terminated early due to rituximab's risk-benefit ratio for individuals with early active Rheumatoid Arthritis. Mechanistic samples were not processed and corresponding endpoints were not assessed. Only descriptive statistics are presented. | |||
| NCT00366704 Details | 2013-02-11 Interventional | 3 | - | Risperidone Schizophrenia | - - | |||
| NCT00724685 2007-002983-89 Details | 2013-02-08 Interventional | 4 | 34 | Ropivacaine Post Operative … | - - | |||
| NCT00137345 Details | 2013-02-08 Interventional | 3 | - | Sirolimus Kidney Transpla… | - - | |||
| NCT01269411 Details | 2013-02-07 Interventional | 1 | 22 | 2,2-dimethyl-N-… Brain Neoplasms Glioblastoma Glioma Gliosarcoma Oligodendroglio… Recurrence Adult Anaplasti… Adult Brain Ste… Adult Giant Cel… Adult Glioblast… Adult Gliosarco… Adult Mixed Gli… Recurrent Adult… | Administratively complete. - | |||
| NCT00177138 Details | 2013-02-07 Interventional | 4 | 9 | Alemtuzumab Tacrolimus Diabetes Mellit… | The clinical use of Campath for transplant patients was temporarily suspended. - | |||
| NCT00005808 Details | 2013-02-07 Interventional | 1 | 54 | Motexafin lutet… Carcinoma in Si… Neoplasms Uterine Cervica… Cervical Cancer Cervical Intrae… Cervical Intrae… | Administratively complete. - | |||
| NCT00066625 Details | 2013-02-01 Interventional | 1 | 30 | Bortezomib Oxaliplatin Unspecified Adu… | Administratively complete. - | |||
| NCT00042835 Details | 2013-02-01 Interventional | 1 | 48 | Carboplatin Docetaxel Erlotinib Hydro… Etoposide Etoposide phosp… Paclitaxel Adenocarcinoma … Adenocarcinoma,… Carcinoma, Non-… Lung Neoplasms Adenocarcinoma … Bronchoalveolar… Large Cell Lung… Squamous Cell L… Stage IIIA Non-… Stage IIIB Non-… | Administratively complete. - | |||
| NCT00039455 Details | 2013-02-01 Interventional | 1 | 50 | Alvocidib Trastuzumab Breast Neoplasm… Breast Neoplasm… HER2-positive B… Male Breast Can… Recurrent Breas… Stage IV Breast… | Administratively complete. - | |||
| NCT00002796 NCT01925326 Details | 2013-02-01 Interventional | 1/2 | 46 | 4-phenylbutyric… Fluorouracil Indomethacin Interferon-gamm… Interferons Adenocarcinoma Adenocarcinoma,… Colonic Neoplas… Cystadenocarcin… Rectal Neoplasm… Recurrence Mucinous Adenoc… Mucinous Adenoc… Recurrent Colon… Recurrent Recta… Signet Ring Ade… Signet Ring Ade… Stage IVA Colon… Stage IVA Recta… Stage IVB Colon… Stage IVB Recta… | Administratively complete. - | |||
| NCT01301313 2009-017827-24 Details | 2013-01-31 Interventional | 2 | 116 | Simendan Heart Failure Acute Heart Fai… | - - | |||
| NCT00840489 Details | 2013-01-31 Interventional | 2 | 50 | Colchicine Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepatitis, Chro… Chronic Hepatit… | Preliminary analysis - |